Get App Open
In App
Lending
Lending
Open App
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 01, 16:01
1958.65 5.95 (0.30%)
Volume
AVERAGE VOLUME
5-Day
21,261
10-Day
26,739
30-Day
20,867
8,175
  • Prev. Close

    1952.70

  • Open Price

    1942.25

  • Bid Price (Qty.)

    1958.65 (1)

  • Offer Price (Qty.)

    1970.00 (10)

NSE Live

Oct 01, 15:50
1959.20 6.50 (0.33%)
Volume
AVERAGE VOLUME
5-Day
671,857
10-Day
693,655
30-Day
712,493
524,801
  • Prev. Close

    1952.70

  • Open Price

    1952.70

  • Bid Price (Qty.)

    1959.20 (1)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Glenmark Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,154.02 7,000.75 1,571.87 2,337.45 1,943.76  
Net CashFlow From Operating Activities 588.80 -495.45 1,474.06 1,216.07 1,243.42  
Net Cash Used In Investing Activities -489.52 3,197.19 -431.47 -896.92 -1,235.23  
Net Cash Used From Financing Activities -95.41 -2,666.45 -978.50 -305.12 -80.79  
Foreign Exchange Gains / Losses -0.38 -0.02 -0.05 -0.10 0.04  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 3.49 35.27 64.05 13.93 -72.57  
Cash And Cash Equivalents Begin of Year 127.96 92.70 28.65 14.72 87.29  
Cash And Cash Equivalents End Of Year 131.45 127.96 92.70 28.65 14.72  
Source : Dion Global Solutions Limited

Results of Glenmark